Finance
CorMedix Inc [CRMD] Revenue clocked in at $0.00 million, up 69.95% YTD: What’s Next?
CorMedix Inc [NASDAQ: CRMD] closed the trading session at $6.39. The company report on April 11, 2024 at 8:30 AM that CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference. The first abstract being presented examines in vitro antimicrobial activity of
